News

New Brain Tumor Clinical Trials: April – October 2024 It can be hard to keep track of new clinical trial opportunities opening across the United States. There are many clinical trials actively enrolling patients. This report provides a summary of the studies that have recently opened or started recruiting since our last report for patients with a primary brain tumor. Follow the hyperlink for […] November 7, 2024

National Brain Tumor Society Celebrates the Introduction of the Bipartisan Bolstering Research and Innovations Now (BRAIN) Act in Congress Landmark legislation aims to invest in research, foster collaboration, improve survivorship and quality of life, and raise awareness of key treatment considerations National Brain Tumor Society, the largest patient advocacy organization in the United States committed to curing brain tumors and improving the lives of patients and families, is proud to share that a once-in-a-generation […] July 23, 2024

Jessica Runs to Raise Awareness After Husband’s Glioblastoma Diagnosis Jessica D. recalls feeding the giraffes at a local zoo with her toddler Ellie and husband Stan, who was not acting like himself and seemed noticeably cranky. The following day, she ran a 5K and returned to her car to find 75 missed calls and text messages because Stan had a suspected seizure at the […] July 12, 2024

Let’s Talk About Glioblastoma Glioblastoma (GBM) is known as the most common, complex, treatment-resistant, and deadliest type of brain cancer. These tumors devastate the brain, which controls cognition, mood, behavior, and personality, as well as every function of each organ and body part. The current standard of care can only prolong a patient’s life by a few months, on […] July 10, 2024

New Brain Tumor Clinical Trials: January – March 2024 It can be hard to keep track of new clinical trial opportunities opening across the United States. There are many clinical trials actively enrolling patients. This report provides a summary of the studies that have recently opened or started recruiting (January 1, 2024 – April 9, 2024) for patients with a primary brain tumor*. Follow […] April 12, 2024